Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions. Duff & Phelps acquired Kroll in 2018 and unified under the Kroll brand in 2022.
Contact Us
Discover how Kroll's M&A Advisory and Investigations teams helped a family company sell their business through constructing a robust financial projection model to attract lenders and investors. Request Our Qualifications
Kroll’s Healthcare M&A practice has extensive experience in the healthcare sector, including Healthcare IT, Facilities and Real Estate, Behavioral Health and Rehabilitation, Home Health and Hospice, Pharmaceutical Services, Payor Services, Outsourced Services and Alternative Site and Ancillary Care. Our dedicated team of healthcare professionals successfully advises clients on even the most complex transactions.
Discover how Kroll's M&A Advisory and Investigations teams helped a family company sell their business through constructing a robust financial projection model to attract lenders and investors. Request Our Qualifications
Connect with us on LinkedIn
Kroll Corporate Finance and Restructuring is now on LinkedIn. Connect with us for the latest insights on investment banking, corporate finance, restructuring and insolvency solutions.
Connect with us
FEATURED CASE STUDIES
Explore areas we can helpStay Ahead with Kroll
Aerospace Defense and Government Services (ADG) Investment Banking
Strategic and financial advisory for Aerospace Defense and Government Services clients worldwide.
Consumer Investment Banking
Consumer, Retail, Food and Restaurant expertise for middle-market M&A transactions.
Energy Investment Banking
Energy and Mining expertise for middle-market M&A transactions.
Industrials Investment Banking
Industrials expertise for middle-market M&A transactions.
Business Services Investment Banking
Business services expertise for middle-market M&A transactions.
Technology Investment Banking
Technology expertise for middle-market M&A transactions.
Explore Insights
M&A Updates
Brazil Transactions Insights – Summer 2023
Sep 04, 2023 Activities in the capital market H1 2023 kept the same level as 2022, with only nine follow-ons totaling BRL 15 bn. Since January 2022, Brazil Capital Markets has no IPO’s.
Environmental, Social and Governance
ESG and Global Investor Returns Study
Sep 13, 2023 In our inaugural study, we examined the relationship between historical returns of publicly traded companies and their ESG ratings.
Cost of Capital
AIRA Journal: Navigating the Uncertainty Around Cost of Capital and Valuation Assumptions
Sep 12, 2023 In this AIRA Journal article, Kroll expert Carla Nunes analyzed the impact of COVID19, geopolitical tensions and high inflation on global financial markets. She also discussed the “higher-for-longer” interest rate environment and the growing specter of bankruptcy and restructuring activity.
M&A Updates
Canadian M&A Industry Insights – Summer 2023
Aug 31, 2023 Canadian M&A activity has declined in deal volume in 1H 2023 compared to 1H 2022 but has increased in disclosed implied enterprise value (EV) – mostly attributed to a few megadeals that closed during the period.
Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on Its Recapitalization by 5th Century Partners
Kroll's Healthcare Investment Banking Team Advised TRI–AD on Its Sale to Navia Benefit Solutions
